Nippon Shinyaku Co., Ltd. (4516.T)
JPY 4157.0
(-0.76%)
JPY 4157.0
(-0.76%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 65.63 Billion JPY | 12.87% |
| 2022 | 58.14 Billion JPY | 6.99% |
| 2021 | 54.34 Billion JPY | 18.68% |
| 2020 | 45.79 Billion JPY | 9.53% |
| 2019 | 41.81 Billion JPY | -3.03% |
| 2018 | 43.11 Billion JPY | 15.18% |
| 2017 | 37.43 Billion JPY | -3.17% |
| 2016 | 38.66 Billion JPY | 22.19% |
| 2015 | 31.64 Billion JPY | 4.78% |
| 2014 | 30.19 Billion JPY | 2.57% |
| 2013 | 29.44 Billion JPY | 4.18% |
| 2012 | 28.26 Billion JPY | 33.79% |
| 2011 | 21.12 Billion JPY | 2.14% |
| 2010 | 20.67 Billion JPY | 3.03% |
| 2009 | 20.07 Billion JPY | 5.05% |
| 2008 | 19.1 Billion JPY | 2.03% |
| 2007 | 18.72 Billion JPY | -2.42% |
| 2006 | 19.19 Billion JPY | -10.26% |
| 2005 | 21.38 Billion JPY | 8.1% |
| 2004 | 19.78 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 16.71 Billion JPY | -21.85% |
| 2023 Q2 | 14.22 Billion JPY | 10.42% |
| 2023 Q1 | 12.88 Billion JPY | -31.35% |
| 2023 FY | 65.63 Billion JPY | 12.87% |
| 2023 Q4 | 21.39 Billion JPY | 35.65% |
| 2023 Q3 | 15.77 Billion JPY | 10.84% |
| 2022 Q3 | 15.39 Billion JPY | 22.46% |
| 2022 Q2 | 12.56 Billion JPY | 10.11% |
| 2022 Q1 | 11.41 Billion JPY | -25.41% |
| 2022 FY | 58.14 Billion JPY | 6.99% |
| 2022 Q4 | 18.77 Billion JPY | 21.95% |
| 2021 FY | 54.34 Billion JPY | 18.68% |
| 2021 Q3 | 13.57 Billion JPY | -2.79% |
| 2021 Q2 | 13.96 Billion JPY | 21.66% |
| 2021 Q1 | 11.47 Billion JPY | -7.96% |
| 2021 Q4 | 15.3 Billion JPY | 12.76% |
| 2020 FY | 45.79 Billion JPY | 9.53% |
| 2020 Q1 | 9.56 Billion JPY | -2.83% |
| 2020 Q3 | 11.64 Billion JPY | -3.81% |
| 2020 Q4 | 12.46 Billion JPY | 7.03% |
| 2020 Q2 | 12.1 Billion JPY | 26.54% |
| 2019 Q2 | 10.41 Billion JPY | 8.06% |
| 2019 Q4 | 9.84 Billion JPY | -17.32% |
| 2019 FY | 41.81 Billion JPY | -3.03% |
| 2019 Q3 | 11.91 Billion JPY | 14.37% |
| 2019 Q1 | 9.63 Billion JPY | -17.12% |
| 2018 Q4 | 11.62 Billion JPY | 9.16% |
| 2018 FY | 43.11 Billion JPY | 15.18% |
| 2018 Q1 | 9.72 Billion JPY | -6.46% |
| 2018 Q2 | 11.1 Billion JPY | 14.2% |
| 2018 Q3 | 10.65 Billion JPY | -4.11% |
| 2017 Q2 | 9.84 Billion JPY | 22.0% |
| 2017 Q1 | 8.07 Billion JPY | -41.62% |
| 2017 FY | 37.43 Billion JPY | -3.17% |
| 2017 Q4 | 10.4 Billion JPY | 14.06% |
| 2017 Q3 | 9.11 Billion JPY | -7.4% |
| 2016 FY | 38.66 Billion JPY | 22.19% |
| 2016 Q1 | 8.17 Billion JPY | 1.3% |
| 2016 Q4 | 13.82 Billion JPY | 59.72% |
| 2016 Q3 | 8.65 Billion JPY | 8.13% |
| 2016 Q2 | 8 Billion JPY | -2.14% |
| 2015 FY | 31.64 Billion JPY | 4.78% |
| 2015 Q4 | 8.07 Billion JPY | 3.04% |
| 2015 Q3 | 7.83 Billion JPY | 4.05% |
| 2015 Q2 | 7.53 Billion JPY | -8.15% |
| 2015 Q1 | 8.19 Billion JPY | 8.91% |
| 2014 FY | 30.19 Billion JPY | 2.57% |
| 2014 Q1 | 7.6 Billion JPY | 0.97% |
| 2014 Q2 | 7.29 Billion JPY | -4.11% |
| 2014 Q3 | 7.76 Billion JPY | 6.47% |
| 2014 Q4 | 7.52 Billion JPY | -3.08% |
| 2013 Q3 | 7.69 Billion JPY | 8.06% |
| 2013 FY | 29.44 Billion JPY | 4.18% |
| 2013 Q1 | 7.09 Billion JPY | -6.41% |
| 2013 Q2 | 7.11 Billion JPY | 0.3% |
| 2013 Q4 | 7.53 Billion JPY | -2.04% |
| 2012 Q4 | 7.58 Billion JPY | -29.96% |
| 2012 Q1 | 4.83 Billion JPY | -12.61% |
| 2012 Q3 | 10.82 Billion JPY | 116.02% |
| 2012 Q2 | 5.01 Billion JPY | 3.6% |
| 2012 FY | 28.26 Billion JPY | 33.79% |
| 2011 Q2 | 5.14 Billion JPY | 2.94% |
| 2011 Q3 | 5.44 Billion JPY | 5.97% |
| 2011 Q4 | 5.53 Billion JPY | 1.6% |
| 2011 FY | 21.12 Billion JPY | 2.14% |
| 2011 Q1 | 4.99 Billion JPY | -9.35% |
| 2010 Q3 | 4.97 Billion JPY | -6.63% |
| 2010 Q2 | 5.32 Billion JPY | 9.17% |
| 2010 Q1 | 4.87 Billion JPY | -8.55% |
| 2010 Q4 | 5.51 Billion JPY | 10.87% |
| 2010 FY | 20.67 Billion JPY | 3.03% |
| 2009 Q4 | 5.33 Billion JPY | 5.58% |
| 2009 FY | 20.07 Billion JPY | 5.05% |
| 2009 Q3 | 5.05 Billion JPY | 0.88% |
| 2009 Q2 | 5 Billion JPY | 6.9% |
| 2009 Q1 | 4.68 Billion JPY | -0.3% |
| 2008 Q2 | 4.93 Billion JPY | 0.0% |
| 2008 FY | 19.1 Billion JPY | 2.03% |
| 2008 Q3 | 5.02 Billion JPY | 1.78% |
| 2008 Q4 | 4.69 Billion JPY | -6.55% |
| 2007 FY | 18.72 Billion JPY | -2.42% |
| 2006 FY | 19.19 Billion JPY | -10.26% |
| 2005 FY | 21.38 Billion JPY | 8.1% |
| 2004 FY | 19.78 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -50.395% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 97.493% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 87.895% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 66.79% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -1656.55% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -126.111% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 87.687% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -1142.541% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 0.263% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | -41.853% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -468.086% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -697.267% |
| Tsumura & Co. | 48.8 Billion JPY | -34.49% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -96.948% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -235.932% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | -2.973% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -418.535% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -62.193% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -44.578% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -1478.807% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -1003.97% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -1156.653% |
| MedRx Co., Ltd | 959 Million JPY | -6743.691% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -2183.827% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -4346.545% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -2668.464% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -171.595% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -85.226% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -8827.189% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 34.249% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -2807.517% |